Tempus AI
Tempus AI sells software and genomic data analysis to hospitals and drugmakers, so it benefits from AI demand only indirectly, as a third-order beneficiary of the compute buildout.
Checked against the company's own business description in its latest annual filing.
Latest disclosed
10-Q filed 2026-07-30 · period ending 2026-06-30
Pieces naming this company
None yet.
No price is shown: the Index is a map of what each company sells and where it sits, not a quote board.